Effect of a patient-centered decision app on TOLAC: An RCT
以患者为中心的决策应用程序对 TOLAC 的影响:随机对照试验
基本信息
- 批准号:8885864
- 负责人:
- 金额:$ 63.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-10 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressBenefits and RisksBirthCaringClinicalConflict (Psychology)DataDecision MakingDiscipline of obstetricsEffectivenessExerciseFrequenciesGoalsHealthHealth TechnologyInterventionKnowledgeLanguageLeadMeasuresNeonatalOutcomePatient PreferencesPatientsPopulationProbabilityProviderPublic HealthRandomizedRiskRoleTrial of LaborVaginal Birth after CesareanWomanWorkbasecohortevidence baseexperienceimprovedinnovationmHealthmaternal morbiditypatient orientedpreferencepregnantprimary outcomerandomized trialshared decision makingtooltreatment as usual
项目摘要
DESCRIPTION (provided by applicant): Cesarean delivery (CD) accounts for one-third of all births in the US, representing an increase of approximately 50% in the last decade. Elective repeat CDs (ERCD) are a significant contributor to the rising cesarean rate, resulting from the combination of an increasing rate of primary CD and a decreasing rate of vaginal birth after cesarean (VBAC). A primary driver of the decreased frequency of VBAC is the decline in frequency with which eligible women elect a trial of labor after cesarean (TOLAC). The reasons for this decline are unclear; in particular, little is known about the extent to which patient preferences have contributed to this decrease. In addition, tools to help patients and providers engage in patient-preference driven, shared decision making regarding approach to delivery after cesarean are lacking. We propose to 1) identify patient preference drivers of delivery approach (TOLAC or ERCD) and mode (VBAC or CD) among 240 English- or Spanish-speaking TOLAC-eligible women; 2) use this data to create an innovative, personalized decision support mHealth app (Prior CD Decision App) that integrates values clarification exercises with a validated VBAC prediction tool; and 3) conduct a randomized trial of the Prior CD Decision App versus usual care among 1650 English- or Spanish-speaking women to assess its effect on TOLAC and VBAC rates and decision quality. Our hypotheses are that compared to women who receive only usual care, women who are randomized to use the Prior CD Decision App will be more likely to undergo TOLAC and have a VBAC and will experience less decisional conflict, be more knowledgeable about TOLAC and ERCD and experience more optimal shared decision making.
描述(由申请人提供):剖腹产 (CD) 占美国新生儿总数的三分之一,在过去十年中增加了约 50%。选择性重复 CD (ERCD) 是剖宫产率上升的一个重要因素,这是原发性 CD 率上升和剖宫产后阴道分娩 (VBAC) 率下降共同作用的结果。 VBAC 频率下降的主要原因是符合条件的妇女选择剖宫产后试产 (TOLAC) 的频率下降。这种下降的原因尚不清楚;特别是,对于患者偏好在多大程度上导致了这种下降,我们知之甚少。此外,还缺乏帮助患者和医疗服务提供者就剖腹产后分娩方式进行患者偏好驱动的共同决策的工具。我们建议 1) 在 240 名符合 TOLAC 资格的讲英语或西班牙语的女性中确定分娩方式(TOLAC 或 ERCD)和模式(VBAC 或 CD)的患者偏好驱动因素; 2) 使用这些数据创建创新的个性化决策支持 mHealth 应用程序(Prior CD Decision App),该应用程序将价值观澄清练习与经过验证的 VBAC 预测工具集成在一起; 3) 在 1650 名讲英语或西班牙语的女性中对 Prior CD Decision App 与常规护理进行随机试验,以评估其对 TOLAC 和 VBAC 率以及决策质量的影响。我们的假设是,与仅接受常规护理的女性相比,被随机分配使用 Prior CD Decision App 的女性将更有可能接受 TOLAC 并进行 VBAC,并且会经历更少的决策冲突,对 TOLAC 和 ERCD 更加了解,并体验更优化的共同决策。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIRIAM KUPPERMANN其他文献
MIRIAM KUPPERMANN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIRIAM KUPPERMANN', 18)}}的其他基金
Promoting Shared Decision Making in Periviable Care: A randomized controlled trial of the Periviable GOALS Decision Support Tool
促进围产期护理中的共同决策:围产期目标决策支持工具的随机对照试验
- 批准号:
10491110 - 财政年份:2021
- 资助金额:
$ 63.74万 - 项目类别:
Promoting Shared Decision Making in Periviable Care: A randomized controlled trial of the Periviable GOALS Decision Support Tool
促进围产期护理中的共同决策:围产期目标决策支持工具的随机对照试验
- 批准号:
10366336 - 财政年份:2021
- 资助金额:
$ 63.74万 - 项目类别:
Promoting Shared Decision Making in Periviable Care: A randomized controlled trial of the Periviable GOALS Decision Support Tool
促进围产期护理中的共同决策:围产期目标决策支持工具的随机对照试验
- 批准号:
10693922 - 财政年份:2021
- 资助金额:
$ 63.74万 - 项目类别:
Understanding preferences regarding the offer of elective induction of labor to inform development of a decision support tool
了解有关选择性引产的偏好,为决策支持工具的开发提供信息
- 批准号:
10730074 - 财政年份:2019
- 资助金额:
$ 63.74万 - 项目类别:
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes
跨学科研究培训,以减少早产差异并改善孕产妇和新生儿结局
- 批准号:
9921460 - 财政年份:2019
- 资助金额:
$ 63.74万 - 项目类别:
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes
跨学科研究培训,以减少早产差异并改善孕产妇和新生儿结局
- 批准号:
10400055 - 财政年份:2019
- 资助金额:
$ 63.74万 - 项目类别:
Transdisciplinary Research Training to Reduce Disparities in Preterm Birth and Improve Maternal and Neonatal Outcomes
跨学科研究培训,以减少早产差异并改善孕产妇和新生儿结局
- 批准号:
10612870 - 财政年份:2019
- 资助金额:
$ 63.74万 - 项目类别:
Effect of a patient-centered decision app on TOLAC: An RCT
以患者为中心的决策应用程序对 TOLAC 的影响:随机对照试验
- 批准号:
9274339 - 财政年份:2014
- 资助金额:
$ 63.74万 - 项目类别:
Effect of a patient-centered decision app on TOLAC: An RCT
以患者为中心的决策应用程序对 TOLAC 的影响:随机对照试验
- 批准号:
8760269 - 财政年份:2014
- 资助金额:
$ 63.74万 - 项目类别:
Expanded Prenatal Testing Options and Informed Choice
扩大产前检测选项和知情选择
- 批准号:
7933158 - 财政年份:2009
- 资助金额:
$ 63.74万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.74万 - 项目类别:
Research Grant














{{item.name}}会员




